Article
Intracellular NASPM allows an unambiguous functional measure of GluA2-lacking…
medRxiv · 2021 · Coombs, I. D.; Bats, C.; Sexton, C. A.; Cull-Candy, S. G.; Farrant, M.
Key facts
| Title | Intracellular NASPM allows an unambiguous functional measure of GluA2-lacking calcium-permeable AMPA receptor prevalence |
|---|---|
| First author | Coombs, I. D.; Bats, C.; Sexton, C. A.; Cull-Candy, S. G.; Farrant, M. |
| Journal | medRxiv |
| Published | Feb 19, 2021 |
| DOI | 10.1101/2021.02.18.431828 |
| Devices mentioned | K922885, K925155 |
| Product codes mentioned | DXN |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1